AFANAT 40MG TABLET

Form: Tablets

Pack Size: 28 TABLETS

Marketed by: NATCO PHARMA LTD (ONCOLOGY DIV)

MRP: ₹4172.69

NATCO PHARMA LTD (ONCOLOGY DIV): Afanat 40MG Tablet, 28 tablets, salt afatinib 40mg. NPPA has revised its MRP from Rs 5,278.13 to Rs 4,172.69 (21% lower) with effect from 09-11-2026; trade rate Rs 3,179.19. Group: EGFR tyrosine kinase inhibitor (targeted therapy). No other manufacturer of this salt and strength is listed here yet. Handling/counselling: take on an empty stomach; early diarrhoea and rash management decides whether patients stay on it. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.